0001127602-22-003426.txt : 20220204
0001127602-22-003426.hdr.sgml : 20220204
20220204172107
ACCESSION NUMBER: 0001127602-22-003426
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220202
FILED AS OF DATE: 20220204
DATE AS OF CHANGE: 20220204
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Ridha Essra
CENTRAL INDEX KEY: 0001888732
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38537
FILM NUMBER: 22594622
MAIL ADDRESS:
STREET 1: C/O AVROBIO, INC.
STREET 2: ONE KENDALL SQUARE, BLDG 300 - SUITE 201
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: AVROBIO, Inc.
CENTRAL INDEX KEY: 0001681087
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 810710585
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: ONE KENDALL SQUARE
STREET 2: BLDG. 300, SUITE 201
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
BUSINESS PHONE: 7819626030
MAIL ADDRESS:
STREET 1: ONE KENDALL SQUARE
STREET 2: BLDG. 300, SUITE 201
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
FORMER COMPANY:
FORMER CONFORMED NAME: AvroBio, Inc.
DATE OF NAME CHANGE: 20160729
4
1
form4.xml
PRIMARY DOCUMENT
X0306
4
2022-02-02
0001681087
AVROBIO, Inc.
AVRO
0001888732
Ridha Essra
C/O AVROBIO, INC.
ONE KENDALL SQUARE, BLD. 300 - SUITE 201
CAMBRIDGE
MA
02139
1
Chief Medical Officer
Stock Option (Right to Buy)
1.84
2022-02-02
4
A
0
75000
0
A
2032-02-01
Common Stock
75000
75000
D
Stock Option (Right to Buy)
1.84
2022-02-02
4
A
0
80000
0
A
2032-02-01
Common Stock
80000
80000
D
25% of the shares shall vest and become exercisable on February 2, 2023, and the remaining 75% shall vest in equal monthly installments thereafter over a 3 year period.
/s/ Christopher Gerry, Attorney in Fact for Essra Ridha
2022-02-04